Per accedir als documents amb el text complet, si us plau, seguiu el següent enllaç: http://hdl.handle.net/2445/120701
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | García del Muro Solans, Xavier |
dc.contributor.author | Marcuello, Eugenio |
dc.contributor.author | Gumá, J. |
dc.contributor.author | Paz-Ares, Luis |
dc.contributor.author | Climent, Miguel Angel |
dc.contributor.author | Carles, Joan |
dc.contributor.author | Sánchez Parra, M. |
dc.contributor.author | Tisaire, J. L. |
dc.contributor.author | Maroto, P. |
dc.contributor.author | Germà Lluch, José Ramón |
dc.date | 2018-03-14T11:21:32Z |
dc.date | 2018-03-14T11:21:32Z |
dc.date | 2002-02-01 |
dc.date | 2018-03-14T11:21:32Z |
dc.identifier.citation | 0007-0920 |
dc.identifier.citation | 529753 |
dc.identifier.uri | http://hdl.handle.net/2445/120701 |
dc.format | 5 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Cancer Research UK |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1038/sj.bjc.6600121 |
dc.relation | British Journal of Cancer, 2002, vol. 86, num. 3, p. 326-330 |
dc.relation | https://doi.org/10.1038/sj.bjc.6600121 |
dc.rights | cc-by-nc-sa (c) García del Muro Solans, Xavier et al., 2002 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by-nc-sa/3.0/es |
dc.subject | Càncer de bufeta |
dc.subject | Cisplatí |
dc.subject | Quimioteràpia del càncer |
dc.subject | Medicaments antineoplàstics |
dc.subject | Malalts de càncer |
dc.subject | Bladder cancer |
dc.subject | Cisplatin |
dc.subject | Cancer chemotherapy |
dc.subject | Antineoplastic agents |
dc.subject | Cancer patients |
dc.title | Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |